Article Text
PostScript
Letter to the Editor
Five years of self-administered hyaluronidase facilitated subcutaneous immunoglobulin (fSCIg) home therapy in a patient with primary immunodeficiency
Statistics from Altmetric.com
Footnotes
Contributors All authors have contributed to the writing and review of the report and meet the criteria for authorship.
Funding SJ is supported by a NISCHR Fellowship.
Competing interests SJ has received support from Baxter, CSL Behring, Shire, Octapharma, SOBI and Biotest for conferences, consulting and research. He is Immunology Editor of JCP.
Provenance and peer review Not commissioned; externally peer reviewed.